Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sijing Li

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Cell Communication and Signaling : CCS|June 8, 2019
Tumor-secreted PAI-1 promotes breast cancer metastasis via the induction of adipocyte-derived collagen remodelingXiaohui Wei, Sijing Li, Jinyong He, et al.
The Lancet. Oncology|December 25, 2025
Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trialChih-Hung Hsu, Zhihao Lu, Shegan Gao, et al.
Cell Death & Disease|February 26, 2025
Atlas of expression of acyl CoA binding protein/diazepam binding inhibitor (ACBP/DBI) in human and mouseSijing Li, Silvia Mingoia, Léa Montégut, et al.
Frontiers in Pharmacology|June 23, 2022
A Simplified Herbal Formula Improves Cardiac Function and Reduces Inflammation in Mice Through the TLR-Mediated NF-κB Signaling PathwayXiaoming Dong, Xiaowei Han, Xiaojiao Zhang, et al.
BMJ Open|May 10, 2023
Efficacy and safety of <i>Ginkgo biloba</i> dropping pills in the treatment of coronary heart disease with stable angina pectoris and depression: study protocol for a randomised, placebo-controlled, parallel-group, double-blind and multicentre clinical trialTingchun Wu, Sijing Li, Ziru Li, et al.
Journal for Immunotherapy of Cancer|July 7, 2023
Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responsesShuai Zhang, Liwei Zhao, Mengfei Guo, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 11, 2025
Huoxue Tongluo tablet enhances atherosclerosis efferocytosis by promoting the differentiation of Trem2<sup>+</sup> macrophages via PPARγ signaling pathwayXingling He, Ziru Li, Sijing Li, et al.
Cell Reports|September 22, 2021
Inappropriate use of antibiotics exacerbates inflammation through OMV-induced pyroptosis in MDR Klebsiella pneumoniae infectionChao Ye, Weiran Li, Ying Yang, et al.
Acta Pharmaceutica Sinica. B|May 25, 2026
Oridonin as a novel KDM5C inhibitor alleviates clonal hematopoiesis-induced cardiac aging <i>via</i> H3K4me3-dependent SASP suppressionXingling Chen, Qiangqiang Zhao, Linhuang Chen, et al.
Journal for Immunotherapy of Cancer|June 30, 2022
Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancerPan Juncheng, Adrien Joseph, Antoine Lafarge, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Cell Communication and Signaling : CCS|June 8, 2019
Tumor-secreted PAI-1 promotes breast cancer metastasis via the induction of adipocyte-derived collagen remodelingXiaohui Wei, Sijing Li, Jinyong He, et al.
The Lancet. Oncology|December 25, 2025
Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trialChih-Hung Hsu, Zhihao Lu, Shegan Gao, et al.
Cell Death & Disease|February 26, 2025
Atlas of expression of acyl CoA binding protein/diazepam binding inhibitor (ACBP/DBI) in human and mouseSijing Li, Silvia Mingoia, Léa Montégut, et al.
Frontiers in Pharmacology|June 23, 2022
A Simplified Herbal Formula Improves Cardiac Function and Reduces Inflammation in Mice Through the TLR-Mediated NF-κB Signaling PathwayXiaoming Dong, Xiaowei Han, Xiaojiao Zhang, et al.
BMJ Open|May 10, 2023
Efficacy and safety of <i>Ginkgo biloba</i> dropping pills in the treatment of coronary heart disease with stable angina pectoris and depression: study protocol for a randomised, placebo-controlled, parallel-group, double-blind and multicentre clinical trialTingchun Wu, Sijing Li, Ziru Li, et al.
Journal for Immunotherapy of Cancer|July 7, 2023
Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responsesShuai Zhang, Liwei Zhao, Mengfei Guo, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 11, 2025
Huoxue Tongluo tablet enhances atherosclerosis efferocytosis by promoting the differentiation of Trem2<sup>+</sup> macrophages via PPARγ signaling pathwayXingling He, Ziru Li, Sijing Li, et al.
Cell Reports|September 22, 2021
Inappropriate use of antibiotics exacerbates inflammation through OMV-induced pyroptosis in MDR Klebsiella pneumoniae infectionChao Ye, Weiran Li, Ying Yang, et al.
Acta Pharmaceutica Sinica. B|May 25, 2026
Oridonin as a novel KDM5C inhibitor alleviates clonal hematopoiesis-induced cardiac aging <i>via</i> H3K4me3-dependent SASP suppressionXingling Chen, Qiangqiang Zhao, Linhuang Chen, et al.
Journal for Immunotherapy of Cancer|June 30, 2022
Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancerPan Juncheng, Adrien Joseph, Antoine Lafarge, et al.
Pageof 11